Paul Maciocia

11PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPhysiotherapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
CD19 chimeric antigen receptor T-cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy.

|Apr 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.

Nicola Maciocia, Malika Hoekx, Ciaran Acuna

|Jan 29, 2025
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.

Mathieu Ferrari, Farhaan Parekh, Paul Maciocia

|Dec 23, 2024
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?

Nicola Maciocia, Brandon Wade, Paul Maciocia

|Nov 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.

Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli

|Oct 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapy.

Orla McCourt, Paul Maciocia, Claire Roddie

Pageof 2

Frequent Collaborators

7 joint publications

Martin Pule

5 joint publications

Mathieu Ferrari

2 joint publications

Giuseppe Gritti

2 joint publications

Amy Burley